XBiotech Inc. (XBIT) › Capital ExpendituresXBiotech Inc. (XBIT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $59.0K2014: $1.40M2015: $2.32M2016: $4.75M2017: $1.41M2018: $122.0K2019: $204.0K2020: $3.73M2021: $3.52M2022: $585.0K2023: $362.0K2024: $1.30M2025: $289.0K$289.0K2013Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$289.0K-77.8%2024$1.30M+260.2%2023$362.0K-38.1%2022$585.0K-83.4%2021$3.52M-5.4%2020$3.73M+1727.0%2019$204.0K+67.2%2018$122.0K-91.3%2017$1.41M-70.4%2016$4.75M+104.4%2015$2.32M+66.2%2014$1.40M+2267.8%2013$59.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share